TERT and neoplasm: In colorectal cancer, miR-138 downregulation was observed in parallel to telomerase reverse transcriptase (TERT) upregulation, suggesting that miR-138-5p works at least partially through TERT downregulation, thus acting as tumor suppressor with the potential to inhibit telomerase expression (23, 24).